Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2008 1
2009 4
2010 4
2011 1
2012 1
2013 2
2014 6
2015 5
2016 3
2017 4
2018 6
2019 5
2020 8
2021 6
2022 4
2023 8
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Results by year

Filters applied: . Clear all
Page 1
Therapeutic Plasma Exchange: Core Curriculum 2023.
Cervantes CE, Bloch EM, Sperati CJ. Cervantes CE, et al. Among authors: sperati cj. Am J Kidney Dis. 2023 Apr;81(4):475-492. doi: 10.1053/j.ajkd.2022.10.017. Epub 2023 Feb 10. Am J Kidney Dis. 2023. PMID: 36775691 Review.
Egad!
Platt L, Deboer SR, Shenderov K, Probasco JC, Guterman EL, Manesh R, Sperati CJ. Platt L, et al. Among authors: sperati cj. J Hosp Med. 2019 Mar;14(3):181-185. doi: 10.12788/jhm.3103. J Hosp Med. 2019. PMID: 30811327 No abstract available.
Drug-Induced Hypertension.
Foy MC, Vaishnav J, Sperati CJ. Foy MC, et al. Among authors: sperati cj. Endocrinol Metab Clin North Am. 2019 Dec;48(4):859-873. doi: 10.1016/j.ecl.2019.08.013. Epub 2019 Sep 17. Endocrinol Metab Clin North Am. 2019. PMID: 31655781 Review.
O Complement, Where Aren't Thou.
Sperati CJ, Chaturvedi S. Sperati CJ, et al. Adv Chronic Kidney Dis. 2020 Mar;27(2):83-85. doi: 10.1053/j.ackd.2020.02.001. Adv Chronic Kidney Dis. 2020. PMID: 32553249 No abstract available.
How I Treat Complement-Mediated TMA.
Sperati CJ. Sperati CJ. Clin J Am Soc Nephrol. 2022 Mar;17(3):452-454. doi: 10.2215/CJN.13581021. Epub 2022 Jan 24. Clin J Am Soc Nephrol. 2022. PMID: 35074846 Free PMC article. No abstract available.
Rapid Progression of Focal Segmental Glomerulosclerosis in Patients with High-Risk APOL1 Genotypes.
Kallash M, Wang Y, Smith A, Trachtman H, Gbadegesin R, Nester C, Canetta P, Wang C, Hunley TE, Sperati CJ, Selewski D, Ayoub I, Srivastava T, Mottl AK, Kopp J, Gillespie B, Robinson B, Chen D, Steinke J, Twombley K, Reidy K, Mucha K, Greenbaum LA, Blazius B, Helmuth M, Yonatan P, Parekh RS, Hogan S, Royal V, D'Agati V, Chishti A, Falk R, Gharavi A, Holzman L, Klein J, Smoyer W, Kretzler M, Gipson D, Kidd JM; CureGN*. Kallash M, et al. Among authors: sperati cj. Clin J Am Soc Nephrol. 2023 Mar 1;18(3):344-355. doi: 10.2215/CJN.0000000000000069. Epub 2023 Feb 8. Clin J Am Soc Nephrol. 2023. PMID: 36763813 Free PMC article.
Fibromuscular dysplasia.
Sperati CJ, Aggarwal N, Arepally A, Atta MG. Sperati CJ, et al. Kidney Int. 2009 Feb;75(3):333-6. doi: 10.1038/ki.2008.232. Epub 2008 Jun 4. Kidney Int. 2009. PMID: 18528320 Free article. No abstract available.
Novel therapeutics in hypertension and kidney disease.
Sperati CJ, Whaley-Connell A. Sperati CJ, et al. Curr Opin Nephrol Hypertens. 2015 Sep;24(5):401-2. doi: 10.1097/MNH.0000000000000156. Curr Opin Nephrol Hypertens. 2015. PMID: 26181780 No abstract available.
Clinical Outcomes of Patients with C3G or IC-MPGN Treated with the Factor D Inhibitor Danicopan: Final Results from Two Phase 2 Studies.
Nester C, Appel GB, Bomback AS, Bouman KP, Cook HT, Daina E, Dixon BP, Rice K, Najafian N, Hui J, Podos SD, Langman CB, Lightstone L, Parikh SV, Pickering MC, Sperati CJ, Trachtman H, Tumlin J, de Vries AP, Wetzels JFM, Remuzzi G. Nester C, et al. Among authors: sperati cj. Am J Nephrol. 2022;53(10):687-700. doi: 10.1159/000527167. Epub 2022 Nov 24. Am J Nephrol. 2022. PMID: 36423588 Free article. Clinical Trial.
65 results